A Systematic Review of the Cost-Effectiveness of Targeted Therapies for Metastatic Non-Small Cell Lung Cancer (NSCLC)
BMC Pulmonary Medicine - United Kingdom
doi 10.1186/1471-2466-14-192
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2014
Authors
Publisher
Springer Science and Business Media LLC